Which closed-end funds own Newamsterdam Pharma Co NV?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $37.4M. Security type: common equity. Country: Netherlands. ISIN NL00150012L7 · ticker NAMS.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THW abrdn World Healthcare Fund | Healthcare | 1.88% | $13M | 382,193 sh | $689M | 4.3% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 1.20% | $8.3M | 244,176 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 1.19% | $16.1M | 476,416 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “NAMS” → · Compare two funds’ portfolios →